Lantheus Holdings Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Lantheus Holdings wird ein Gewinn- und Umsatzwachstum von 11% bzw. 13% pro Jahr prognostiziert, während der Gewinn pro Aktie um 8.7% pro Jahr wachsen soll.
Wichtige Informationen
10.3%
Wachstumsrate der Gewinne
8.5%
EPS-Wachstumsrate
Medical Equipment Gewinnwachstum | 16.7% |
Wachstumsrate der Einnahmen | 13.6% |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 01 Jul 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt
Jun 24Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus
May 23Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
May 10Lantheus Holdings: Powerful First Quarter
May 05Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital
Apr 12Lantheus Holdings: Undervalued With A Good Outlook
Feb 28Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
Feb 24Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly
Feb 08Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings
Jan 03Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing
Dec 16A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Nov 28Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?
Nov 09Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down
Sep 04Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Aug 09Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?
Jul 22Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively
May 29Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly
Apr 16Capital Allocation Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Ideal
Feb 27An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 48% Undervalued
Jan 16Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt
Dec 24Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively
Oct 31Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?
Oct 04Looking In On Lantheus Holdings
Sep 14Lantheus Holdings a buy at B Riley on growth spurred by approval of imaging agent
Aug 25Lantheus Non-GAAP EPS of $0.89 beats by $0.19, revenue of $223.72M beats by $19.21M
Aug 04Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital
Jul 22Lantheus Holdings Rules The Medical Diagnostics Business World
Jul 06We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease
Jun 25Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 1,820 | 598 | 642 | 654 | 7 |
12/31/2025 | 1,562 | 418 | 684 | 341 | 9 |
12/31/2024 | 1,507 | 474 | 777 | 542 | 11 |
3/31/2024 | 1,366 | 461 | 268 | 324 | N/A |
12/31/2023 | 1,296 | 327 | 213 | 305 | N/A |
9/30/2023 | 1,206 | 104 | -46 | 298 | N/A |
6/30/2023 | 1,125 | 33 | -61 | 275 | N/A |
3/31/2023 | 1,027 | -18 | 60 | 380 | N/A |
12/31/2022 | 935 | 28 | 3 | 282 | N/A |
9/30/2022 | 801 | 107 | 172 | 190 | N/A |
6/30/2022 | 664 | 32 | 87 | 101 | N/A |
3/31/2022 | 542 | -37 | 42 | 54 | N/A |
12/31/2021 | 425 | -71 | 42 | 54 | N/A |
9/30/2021 | 390 | -34 | 29 | 41 | N/A |
6/30/2021 | 376 | -27 | 32 | 45 | N/A |
3/31/2021 | 341 | -8 | 5 | 17 | N/A |
12/31/2020 | 339 | -13 | 4 | 16 | N/A |
9/30/2020 | 335 | 0 | 25 | 38 | N/A |
6/30/2020 | 332 | 12 | 43 | 56 | N/A |
3/31/2020 | 352 | 25 | 65 | 79 | N/A |
12/31/2019 | 347 | 32 | 58 | 80 | N/A |
9/30/2019 | 344 | 35 | 51 | 75 | N/A |
6/30/2019 | 347 | 39 | 47 | 73 | N/A |
3/31/2019 | 347 | 42 | 44 | 72 | N/A |
12/31/2018 | 343 | 41 | 41 | 61 | N/A |
9/30/2018 | 338 | 124 | 38 | 57 | N/A |
6/30/2018 | 329 | 124 | 31 | 48 | N/A |
3/31/2018 | 333 | 127 | 34 | 49 | N/A |
12/31/2017 | 331 | 123 | N/A | 55 | N/A |
9/30/2017 | 324 | 31 | N/A | 54 | N/A |
6/30/2017 | 318 | 27 | N/A | 54 | N/A |
3/31/2017 | 307 | 21 | N/A | 51 | N/A |
12/31/2016 | 302 | 27 | N/A | 50 | N/A |
9/30/2016 | 299 | 26 | N/A | 49 | N/A |
6/30/2016 | 300 | 27 | N/A | 39 | N/A |
3/31/2016 | 295 | -5 | N/A | 10 | N/A |
12/31/2015 | 293 | -15 | N/A | 22 | N/A |
9/30/2015 | 299 | -18 | N/A | 5 | N/A |
6/30/2015 | 301 | -25 | N/A | 20 | N/A |
3/31/2015 | 303 | -2 | N/A | 27 | N/A |
12/31/2014 | 302 | -4 | N/A | 12 | N/A |
9/30/2014 | 296 | -16 | N/A | 12 | N/A |
6/30/2014 | 291 | -30 | N/A | -5 | N/A |
3/31/2014 | 286 | -43 | N/A | -15 | N/A |
12/31/2013 | 284 | -62 | N/A | -16 | N/A |
9/30/2013 | 284 | -59 | N/A | -34 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: LNTHDas prognostizierte Gewinnwachstum (11% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: LNTHDie Erträge des Unternehmens (11% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.7% pro Jahr).
Hohe Wachstumserträge: LNTHDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: LNTHDie Einnahmen des Unternehmens (13% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.5% pro Jahr).
Hohe Wachstumseinnahmen: LNTHDie Einnahmen des Unternehmens (13% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von LNTH in 3 Jahren voraussichtlich hoch sein wird